AURKB
Aurora kinase B
Also known as: Aik2, AIM-1, ARK2, AurB, AURKB_HUMAN, IPL1, PPP1R48, STK12, STK5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96GD4
- Gene
- AURKB
- Ensembl
- ENSG00000178999
- Chromosome
- 17
- Canonical length
- 344 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Midbody
OverviewNCBI Gene
This gene encodes a member of the aurora kinase subfamily of serine/threonine kinases. The genes encoding the other two members of this subfamily are located on chromosomes 19 and 20. These kinases participate in the regulation of alignment and segregation of chromosomes during mitosis and meiosis through association with microtubules. A pseudogene of this gene is located on chromosome 8. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2015]
Canonical amino-acid sequenceUniProt
344 residues, UniProt reviewed canonical sequence.
>Q96GD4|AURKB
1 MAQKENSYPW PYGRQTAPSG LSTLPQRVLR KEPVTPSALV LMSRSNVQPT AAPGQKVMEN
61 SSGTPDILTR HFTIDDFEIG RPLGKGKFGN VYLAREKKSH FIVALKVLFK SQIEKEGVEH
121 QLRREIEIQA HLHHPNILRL YNYFYDRRRI YLILEYAPRG ELYKELQKSC TFDEQRTATI
181 MEELADALMY CHGKKVIHRD IKPENLLLGL KGELKIADFG WSVHAPSLRR KTMCGTLDYL
241 PPEMIEGRMH NEKVDLWCIG VLCYELLVGN PPFESASHNE TYRRIVKVDL KFPASVPMGA
301 QDLISKLLRH NPSERLPLAQ VSAHPWVRAN SRRVLPPSAL QSVALocalizationUniProt · AlphaFold · HPA
Whether an antibody against AURKB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- thymus: 56 nTPM
- bone marrow: 42 nTPM
- lymph node: 34 nTPM
- tonsil: 34 nTPM
- esophagus: 18 nTPM
- appendix: 13 nTPM
Single-cell type
- extravillous trophoblasts: 103 nCPM
- monocyte progenitors: 81 nCPM
- migrating cytotrophoblasts: 77 nCPM
- enteric transient amplifying cells: 60 nCPM
- esophageal basal cells: 60 nCPM
- erythrocyte progenitors: 50 nCPM
Immune cell
- T-reg: 7.9 nTPM
- naive B-cell: 2.5 nTPM
- memory CD8 T-cell: 2.1 nTPM
- memory CD4 T-cell: 1.3 nTPM
- memory B-cell: 1.1 nTPM
- neutrophil: 0.9 nTPM
Brain region
- thalamus: 1.1 nTPM
- pons: 0.9 nTPM
- cerebellum: 0.7 nTPM
- hypothalamus: 0.7 nTPM
- white matter: 0.7 nTPM
- basal ganglia: 0.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AURKB.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 47 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on AURKB was assayed in.
- acute myeloid leukemia T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.74
- DepMap mean gene effect
- -2.3
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell cycle G2/M phase transition
- cellular response to UV
- cleavage furrow formation
- midbody abscission
- mitotic cell cycle
- mitotic cytokinesis
- mitotic cytokinesis checkpoint signaling
- mitotic sister chromatid biorientation
- mitotic spindle assembly
- mitotic spindle midzone assembly
- mitotic spindle organization
- negative regulation of B cell apoptotic process
- negative regulation of cGAS/STING signaling pathway
- negative regulation of cytokinesis
- negative regulation of innate immune response
- negative regulation of protein localization to chromatin
- negative regulation of transcription by RNA polymerase II
- positive regulation of attachment of mitotic spindle microtubules to kinetochore
- positive regulation of cytokinesis
- positive regulation of microtubule depolymerization
- positive regulation of mitotic cell cycle spindle assembly checkpoint
- positive regulation of mitotic cytokinesis
- positive regulation of mitotic sister chromatid segregation
- positive regulation of mitotic sister chromatid separation
- positive regulation of telomere maintenance
- post-translational protein modification
- protein localization to kinetochore
- regulation of chromosome segregation
- regulation of cytokinesis
- regulation of signal transduction by p53 class mediator
- repair of mitotic kinetochore microtubule attachment defect
- spindle organization
- positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore
Molecular functions
- ATP binding
- kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein serine/threonine/tyrosine kinase activity
- histone H1-4S27 kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AURKB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AURKB as an antibody target. Whether an autoantibody or antibody against AURKB could matter depends on whether native AURKB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AURKB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AURKB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...